Oral calcitriol: a new therapeutic agent in cutaneous lichen sclerosis

Journal of Drugs in Dermatology, Jan, 2003 by S Ronger, AM Viallard, Meunier-Mure F, B Chouvet, B Balme, L Thomas

(53.) Bodemer C, Amoric JC, Hamel Teillac D, De Prost Y. Localized scleroderma in children and a therapeutic trial using calcitriol: a therapeutic possibility to define. Ann Dermatol Venereol 1999; 126:725-726.

(54.) Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K et al. Combined treatment with calcipotriol ointment and low dose ultraviolet A1 phototherapy in childhood morphea. Pediatric Dermatol 2001; 18:241-45.

(55.) Cunningham BB, Landells ID, Langman C, Sailer DE, Pallet AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998; 39:211-215.

(56.) Boelsma E, Pavel S, Ponec M. Effects of Calcitriol on fibroblasts derived from skin of scleroderma patients. Dermatology 1995; 191/3:226-233

(57.) Lemire J. 1,25 Dihydroxyvitamin D3: a hormone with immunomodulatory properties. Z Rheumatol 2000; 59: 24-27.

ADDRESS FOR CORRESPONDENCE:

Luc Thomas

Hotel Dieu Hospital

1 place de l' Hopital

69288 Lyon cedex 02, France

E-mail: luc.thomas@chu-lyon.fr

S RONGER MD, AM VIALLARD MD, F MEUNIER-MURE MD, B CHOUVET MD, B BALME MD, L THOMAS MD

DEPARTMENT OF DERMATOLOGY, HOTEL DIEU HOSPITAL, LYON, FRANCE.